The overall survival of patients with advanced pancreatic cancer is short, i.e., the overall survival of patients is about 6 months with interventional or other treatments. Advanced pancreatic cancer indicates that the pancreatic tumor is large or has metastasized, including tumor invasion to the superior mesenteric artery, portal vein or lymph node metastasis, as well as liver metastasis, which cannot be removed surgically and requires other treatments such as chemotherapy or interventional treatment. Overall, the survival of patients is low. For advanced pancreatic cancer treatment, there is no particularly good solution, including chemotherapy and interventional treatment effects may not have satisfactory results, but each patient’s situation is different and has different sensitivity to chemotherapy, so advanced pancreatic cancer should also be treated aggressively when conditions are available.